Abstract
Hypervirulent Klebsiella pneumoniae (hvKp) is a new emerging variant of K. pneumoniae that is increasingly reported worldwide. The variant hvKp is known to cause severe invasive community-acquired infections such as metastatic meningitis, pyogenic liver abscesses (PLA) and endophthalmitis, but its role in hospital-acquired infections (HAIs) is little known. The aim of this study was to evaluate the prevalence of hvKp among hospital-acquired (HA) K. pneumoniae infections in the intensive care unit (ICU) and to compare between hvKp and classical K. pneumoniae (cKP) regarding antimicrobial resistance pattern, virulence and molecular characteristics. The study was cross-sectional and included 120 ICU patients suffering from HA K. pneumoniae infections between January and September 2022. K. pneumoniae isolates were subjected to antimicrobial susceptibility testing and detection of extended-spectrum-β-lactamase (ESBL) production by the Phoenix 100 automated microbiology system, string test, biofilm formation, serum resistance assay, and detection of virulence-associated genes (rmpA, rmpA2, magA, iucA) and capsular serotype-specific genes (K1, K2, K5, K20, K57) by polymerase chain reaction (PCR). Of 120 K. pneumoniae isolates, 19 (15.8%) were hvKp. The hypermucoviscous phenotype was more significantly detected in the hvKp group than in the cKP group (100% vs. 7.9%, p ≤ 0.001). The rate of resistance to different antimicrobial agents was significantly higher in the cKP group than that in the hvKp group. Fifty-three strains were identified as ESBL-producing strains, which was more frequent in the cKP group than in the hvKp group (48/101 [47.5%] vs. 5/19 [26.3%], respectively, p ≤ 0.001). The hvKP isolates were highly associated with moderate and strong biofilm formation than cKP isolates (p = 0.018 and p = 0.043 respectively). Moreover, the hvKP isolates were highly associated with intermediate sensitivity and re sistance to serum in the serum resistance assay (p = 0.043 and p = 0.016 respectively). K1, K2, rmpA, rmpA2, magA and iucA genes were significantly associated with hvKp (p ≤ 0.001, 0.004, <0.001, <0.001, 0.037 and <0.001, respectively). However, K5, K20 and K57 were not associated with hvKp. The hvKp strains have emerged as a new threat to ICU patients because of their ability to cause more severe and life-threatening infections than cKP. The string test alone as a laboratory test for screening of hvKp has become insufficient. Recently, hvKp was defined as hypermucoviscous- and aerobactin-positive. It is important to improve the awareness towards the diagnosis and management of hvKp infections.
Keywords: hospital-acquired, hypervirulent, Klebsiella pneumonia, hvKp, intensive care unit, emergence, antimicrobial resistance, Saudi Arabia
1. Introduction
Klebsiella pneumoniae (Kp) is a clinically important member of the Enterobacteriaceae family that can cause a wide range of infections such as pneumonia, urinary tract, bacteremia and wound infections. K. pneumonae usually cause hospital-acquired infections (HAIs) and occur primarily in patients with impaired immunity. Klebsiella pneumoniae has two different pathotypes: classical (cKp), which is the most common subtype of the K. pneumoniae strains that has received increased notoriety due to its ability to develop multidrug resistance and a new emerging variant termed hypervirulent (hvKp) [1,2,3]. The variant hvKp was first recognized in Taiwan in 1986 [4]. The hvKp strains are able to cause metastatic and life-threatening infections in immunocompetent and young healthy individuals. The variant hvKp is a leading cause of pyogenic liver abscesses (PLA) and it has also been implicated in metastatic meningitis and endophthalmitis. The variant hvKp has a characteristic hypermucoviscous colonies when grown on an agar plate, which can be detected by string test [5]. However, there are some controversies about the definition of hvKp. Many factors should be considered such as host, pathogen and host–pathogen interactions when defining hvKp. Nevertheless, most published papers have concentrated only on the bacteria. A previous study revealed that nutritional status, major histocompatibility complex (MHC) variants, composition of gut microbiota and eating habits are important host factors to investigate in order to improve our understanding of the hypervirulence phenomenon [6]. In addition, some controversies have arisen regarding the relationship between hypermucoviscous phenotype and virulence. Using in vivo and in vitro experiments, several studies revealed that few hypermucoviscous K. pneumonia (hmvKp) isolates are associated with high virulence [7,8]. In animal models, hmvKp did not show more serious infections or a higher mortality rate than non-hmvKp. Therefore, hvKp cannot be defined by string test alone [6,9].
Currently, aerobactin has been considered to be a crucial virulence factor for hvKp, which is often associated with the hypermucoviscous phenotype. Based on this finding, research conducted in China that included multiple centres first described the clinical and molecular characteristics of hvKp (defined as aerobactin-positive) isolates. The results revealed that invasive infections, especially PLA, hypermucoviscous phenotype and most of the virulence factors such as rmpA, rmpA2 (both regulators of the mucoid phenotype), and magA (mucoviscosity-associated gene) and capsular serotype-specific genes (K1, K2), are strongly associated with aerobactin-positive Kp [9,10,11]. Furthermore, some studies have revealed that iron acquisition genes and the genes that encode the hypermucoviscous phenotype are situated on the same virulence plasmid, which is present in most hvKp isolates but rarely present in cKp strains [12,13,14]. Thus, it may be more appropriate to combine aerobactin positivity and hypermucoviscosity when defining hvKp.
This study was conducted to evaluate the prevalence of hvKp among hospital-acquired (HA) K. pneumoniae infections in the intensive care unit (ICU) and to compare hvKp and classical K. pneumoniae (cKp) regarding antimicrobial resistance pattern, virulence and molecular characteristics.
2. Methods
2.1. Patients
The study was cross-sectional and included 120 ICU patients suffering from HA K. pneumoniae infections in Prince Mutaeb Bin Abdulaziz Hospital, Aljouf, Kingdom of Saudi Arabia between January and September 2022. Duplicate isolates from the same patient were excluded. Infections were considered as HA when a new infection developed 48 h after patient admission.
2.2. Clinical K. pneumoniae Isolates
The strains were isolated from the following clinical specimens: respiratory secretions, urine, blood and wound swabs. The strains were identified by the Phoenix 100 automated microbiology system (BD, Franklin Lakes, NJ, USA). The hvKp strains were defined as hypermucoviscous- and aerobactin-positive, which was confirmed by string test and PCR, respectively. The strains were stored on glycerol at −80 °C until PCR was performed.
2.3. Antibiotic Susceptibility Testing and Detection of ESBL Production
The susceptibility of the isolates to clinically relevant antibiotics (amikacin, gentamycin, imipenem, meropenem, cefoxitin, ceftazidime, ceftriaxone, cefepime, aztreonam, ampicillin, amoxicillin- clavulanate, piperacillin-tazobactam, trimethoprime-sulphamethoxazole, ciprofloxacin, levofloxacin) and screening for extended-spectrum β-lactamase (ESBL) production were determined using the Phoenix 100 automated microbiology system.
2.4. String Test
Bacterial colonies grown overnight on a blood agar plate at 37 °C were stretched by a standard bacteriological loop. If a mucoviscous string > 5 mm in length was formed, the string test was considered positive and the isolate was identified as hypermucoviscous [15].
2.5. Biofilm Formation
Biofilm formation was examined by using the semi-quantitative assay in 96-well flat bottom plates as previously described [16].
2.6. Serum Resistance Assay
The serum resistance assay was performed as previously described [15]. Then, viable counts (VCs) of bacteria were determined for a period of 3 h. Responses were classified into six grades as follows: highly sensitive (grade 1 and 2), intermediately sensitive (grade 3 and 4), or resistant (grade 5 and 6) [17].
2.7. Detection of Capsular Serotype-Specific Genes and Virulence-Associated Genes
Detection of capsular serotype-specific genes (K1, K2, K5, K20 and K57) and virulence-associated genes (rmpA, rmpA2, magA and iucA) were performed by polymerase chain reaction (PCR). The presence of the iucA gene was used to identify hvKp.
All isolated K. pneumoniae strains were subjected to DNA extraction by the boiling method as previously described [18]. The PCR used for amplification of capsular serotype-specific genes (K1, K2, K5, K20 and K57) was conducted as previously described [19]. PCR for detection of virulence-associated genes (rmpA, rmpA2 and magA) was applied as previously described [20,21]. PCR conditions for amplification of iucA (aerobactin) were as follows: initial denaturation at 95 °C for 15 min, followed by denaturation at 95 °C for 15 s, annealing at 49 °C for 15 min and extension at 72 °C for 1 min for 30 cycles followed by a final extension at 72 °C for 10 min. Primers used in this study are listed in Table 1. Then, the PCR products were subjected to electrophoresis at 100 V for 2 h in a 2% agarose gel containing ethidium bromide (0.5 µg/mL). DNA bands were visualized by UV illumination at 302 nm on a UV transilluminator.
Table 1.
List of primers used in the study.
| Gene | Primers Sequences | Reference | |
|---|---|---|---|
| rmpA | Forward Reverse |
5′-ACTGGGCTACCTCTGCTTCA-3′ | [20] |
| 5′-CTTGCATGAGCCATCTTTCA-3′ | |||
| rmpA2 | Forward Reverse |
5′-CTTTATGTGCAATAAG-GATGTT-3′ | [21] |
| 5′-CCTCCTGGAGAGTAAGCATT-3′ | |||
| magA | Forward Reverse |
5′-GGTGCTCTTTACATCATTGC-3′ | [20] |
| 5′-GCAATGGCCATTTGCGTTAG-3′ | |||
| icuA | Forward Reverse |
5′-GCATAGGCGGATACGAACAT-3′ | [10] |
| 5′-CACAGGGCAATTGCTTACCT-3′ | |||
| K1 | Forward Reverse |
5′-GTAGGTATTGCAAGCCATGC-3′ | [19] |
| 5′-GCCCAGGTTAATGAATCCGT-3′ | |||
| K2 | Forward Reverse |
5′-GGAGCCATTTGAATTCGGTG-3′ | [19] |
| 5′-TCCCTAGCACTGGCTTAAGT-3′ | |||
| K5 | Forward Reverse |
5′-GCCACCTCTAAGCATATAGC-3′ | [19] |
| 5′-CGCACCAGTAATTCCAACAG-3′ | |||
| K20 | Forward Reverse |
5′-CCGATTCGGTCAACTAGCTT-3′ | [19] |
| 5′-GCACCTCTATGAACTTTCAG-3′ | |||
| K57 | Forward Reverse |
5′-CGACAAATCTCTCCTGACGA-3′ | [19] |
| 5′-CGCGACAAACATAACACTCG-3′ |
2.8. Statistical Analysis
Statistical Package for Social Sciences (SPSS) version 20 was used for statistical analysis of the data. Qualitative data were described as numbers and percentages. Comparisons between groups were performed by chi-square test or Fisher’s exact test. Test results with p < 0.05 were considered significant.
3. Results
3.1. Patient Characteristics
This study included 120 ICU patients who were suffering from HA K. pneumoniae infections in Prince Mutaeb Bin Abdulaziz Hospital, Aljouf, Kingdom of Saudi Arabia. Sixty-six (55%) patients were males and 54 (45%) were females; the mean age was 51.78 ± 1.56 (mean ± SE) years. HvKP were defined as hypermucoviscous- and aerobactin-positive isolates were confirmed by string test and PCR, respectively. Nineteen out of one hundred twenty (15.8%) isolates were hvKp. The strains were isolated from the clinical specimens as follows: 48 (40%) from respiratory secretions (hvKp 7.5%, cKp 32.5%), 38 (31.66%) from urine (hvKp 6.66%, cKp 25%), 18 (15%) from blood (hvKp 0%, cKp 15%) and 16 (13.3%) from wound (hvKp 1.66%, cKp 11.66%). A significantly higher number of patients with cKp in respiratory secretions was detected (p = 0.0241). Otherwise, no significant differences were detected in between the isolation of hvKp and cKp isolates in any of the specimen types. The mean age of hvKp-infected patients was significantly younger than that of cKp-infected patients (31.26 ± 0.47 years vs. 55.63 ± 1.43 years, respectively, p ≤ 0.001). Microbiological and genetic characteristics of hvKp isolates are shown in Table 2.
Table 2.
Virulence, microbiological and genetic characteristics of hvKp isolates.
| No. | Specimen | Biofilm Formation | Serum Resistance | Capsule | rmpA | rmpA2 | magA | iucA | String Test |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Tracheal wash | Moderate | Resistant | K1 | + | + | + | + | + |
| 2 | Tracheal wash | Moderate | Resistant | K2 | + | + | + | + | + |
| 3 | Urine | Moderate | Resistant | K1 | − | + | + | + | + |
| 4 | Wound | Strong | Intermediate sensitive | K1 | + | − | − | + | + |
| 5 | Urine | Moderate | Resistant | - | + | + | + | + | + |
| 6 | Sputum | Moderate | Intermediate sensitive | K1 | + | − | + | + | + |
| 7 | Urine | Strong | Intermediate sensitive | K2 | + | − | + | + | + |
| 8 | Urine | Moderate | Resistant | K57 | − | + | − | + | + |
| 9 | Sputum | Strong | Intermediate sensitive | K1 | + | + | + | + | + |
| 10 | Urine | Moderate | Resistant | - | + | + | + | + | + |
| 11 | Tracheal wash | Strong | Resistant | K1 | + | + | + | + | + |
| 12 | Tracheal wash | Moderate | Resistant | K2 | + | + | + | + | + |
| 13 | Sputum | Strong | Intermediate sensitive | K1 | + | + | + | + | + |
| 14 | wound | Moderate | Intermediate sensitive | K2 | − | + | + | + | + |
| 15 | Urine | Strong | Intermediate sensitive | − | + | − | + | + | + |
| 16 | Sputum | Strong | Resistant | − | + | + | - | + | + |
| 17 | Urine | Strong | Intermediate sensitive | K1 | + | − | + | + | + |
| 18 | Sputum | Strong | Intermediate sensitive | − | + | + | − | + | + |
| 19 | Urine | Strong | Intermediate sensitive | − | + | + | + | + | + |
3.2. Comparison between hvKp and cKp Isolates Regarding Antimicrobial Susceptibility Testing and ESBL Production
The rate of resistance to antimicrobial agents was significantly higher in cKp than in hvKp strains, except ampicillin (all hvKp strains were resistant to ampicillin). Fifty-five strains were identified as ESBL-producing strains, which was more significantly detected in the cKp strains than in the hvKp strains (51/101 [50.5%] vs. 4/19 [20.05%], respectively, p = 0.018). The results of antibiotic susceptibility testing and ESBL production for hvKp and cKp are shown in Table 3.
Table 3.
The antimicrobial resistance pattern and ESBL production in hvKp vs. cKp.
| Antimicrobial Agent | HvKp (n = 19) No. (%) |
cKp (n = 101) No. (%) |
p-Value |
|---|---|---|---|
| ESBL production | 4 (21.05%) | 51 (50.5%) | 0.018 |
| Amikacin | 1 (5.3%) | 10 (9.9%) | 0.524 |
| Gentamycin | 2 (10.5%) | 56 (55.4%) | <0.001 |
| Ampicillin/clavulanic | 4 (21%) | 53 (52.5%) | 0.022 |
| Aztreonam | 5 (26.3%) | 44 (43.6%) | 0.163 |
| Cefepime | 2 (10.5%) | 51 (50.5%) | <0.001 |
| Ceftriaxone | 5 (26.3%) | 71 (70.3%) | <0.001 |
| Ceftazidime | 5 (26.3%) | 60 (59.4%) | 0.002 |
| Ciprofloxacin | 7 (36.8%) | 83 (82.2%) | <0.001 |
| Levofloxacin | 5 (26.3%) | 60 (59.4%) | 0.007 |
| Trimethoprim/Sulfamethoxazole | 2 (10.5%) | 70 (69.3%) | <0.001 |
| Piperacillin/Tazobactam | 2 (10.5%) | 53 (52.5%) | 0.003 |
| Imipenem | 0 (00.00%) | 2 (1.9%) | - |
| Meropenem | 1 (5.3%) | 5 (4.9%) | 0.954 |
| Ampicillin | 19 (100%) | 97 (96%) | 0.613 |
| Cefoxitin | 4 (21%) | 32 (31.7%) | 0.4006 |
3.3. Comparison between hvKP and cKP Isolates Regarding Biofilm Formation and Serum
The hypermucoviscous phenotype (based on the string test) was detected in 27 (22.5%) of all K. pneumoniae strains and this phenotype was more frequent in hvKp isolates than in cKp isolates (100% vs. 7.9%, p ≤ 0.001).
3.4. Comparison between non ESBL Producing hvKp and non ESBL Producing cKp Isolates Regarding Biofilm Formation and Serum Resistance
The hvKp isolates were highly associated with moderate and strong biofilm formation than the cKp isolates (p = 0.018 and p = 0.043, respectively). Moreover, the hvKp isolates were highly associated with intermediate sensitivity and resistance to serum in the serum resistance assay (p = 0.043 and p = 0.016, respectively). Results are shown in Table 4.
Table 4.
Biofilm formation and serum resistance assay of non ESBL producing hvKP vs. non ESBL producing cKP.
| Non-ESBL-Producing hvKp (n = 15) No. (%) |
Non-ESBL-Producing cKp (n = 50) No. (%) |
p-Value | |
|---|---|---|---|
| Biofilm Formation: | |||
| Non/weak | 0 (0%) | 37 (74%) | <0.001 |
| Moderate | 7 (46.66%) | 4 (8%) | 0.018 |
| Strong | 8 (53.33%) | 9 (18%) | 0.043 |
| Serum Resistance Assay: | |||
| Sensitive | 0 (0%) | 38 (76%) | <0.001 |
| Intermediate sensitive | 8 (53.33%) | 9 (18%) | 0.043 |
| Resistance | 7 (46.66%) | 3 (6%) | 0.016 |
3.5. Comparison between non ESBL Producing hvKP and ESBL Producing cKP Isolates Regarding Biofilm Formation
The hvKp isolates were highly associated with moderate biofilm formation and intermediate sensitivity to serum in the serum resistance assay than the ESBL-producing cKp isolates (p = 0.044 and p = 0.031, respectively). There were no significant differences with strong biofilm formation and resistance to serum in serum resistance assay between hvKp and ESBL-producing cKp isolates (p = 0.621 and p = 0.542, respectively). Results are shown in Table 5.
Table 5.
Biofilm formation and serum resistance assay of non ESBL producing hvKp vs. ESBL-producing cKp.
| Non-ESBL-Producing hvKp (n = 15) No. (%) |
ESBL-Producing cKp (n = 51) No. (%) |
p-Value | |
|---|---|---|---|
| Biofilm Formation: | |||
| Non/weak | 0 (0%) | 10 (19.6%) | <0.001 |
| Moderate | 7 (46.66%) | 8 (15.7%) | 0.044 |
| Strong | 8 (53.33%) | 33 (64.7%) | 0.621 |
| Serum Resistance Assay: | |||
| Sensitive | 0 (0%) | 11 (21.6%) | <0.001 |
| Intermediate sensitive | 8 (53.33%) | 8 (15.7%) | 0.031 |
| Resistance | 7 (46.66%) | 28 (55%) | 0.542 |
3.6. Comparison between ESBL-Producing hvKp and ESBL-Producing cKp Isolates Regarding Biofilm Formation and Serum Resistance
There was no significant difference between ESBL-producing hvKp and ESBL-producing cKp isolates regarding biofilm formation or serum resistance assay (all p > 0.05). Results are shown in Table 6.
Table 6.
Biofilm formation and serum resistance assay of ESBL-producing hvKp vs. ESBL-producing cKp.
| ESBL-Producing hvKp (n = 4) No. (%) |
ESBL-Producing cKp (n = 51) No. (%) |
p-Value | |
|---|---|---|---|
| Biofilm Formation: | |||
| Non/weak | 0 (0%) | 10 (19.6%) | <0.001 |
| Moderate | 1 (25%) | 8 (15.7%) | 0.954 |
| Strong | 3 (75%) | 33 (64.7%) | 0.524 |
| Serum Resistance Assay: | |||
| Sensitive | 0 (0%) | 11 (21.6%) | <0.001 |
| Intermediate sensitive | 1 (25%) | 8 (15.7%) | 0.613 |
| Resistance | 3 (75%) | 28 (55%) | 0.452 |
3.7. Comparison between hvKp and cKp Isolates Regarding Genetic Characteristics
All isolated strains were tested for virulence-associated genes (rmpA, rmpA2, magA and aerobactin) and Capsular serotype-specific genes (K1, K2, K5, K20 and K57) by PCR. In this study, K1, K2, rmpA, rmpA2, magA and aerobactin were significantly associated with hvKp strains (p ≤ 0.001, 0.004, <0.001, <0.001, 0.037 and <0.001, respectively). Nevertheless, K5, K20 and K57 were not significantly associated with hvKp strains.
3.8. Comparison between hvKp and cKp Isolates Regarding Risk Factors and Associated Invasive Infections
Diabetes mellitus was a statistically significant risk factor associated with hvKp isolates (78.9% in hvKp vs. 35.6% in cKp, p = 0.003). On the other hand, there were no significant differences between hvKp and cKp strains regarding other underlying conditions of patients. Invasive infections were more significantly detected in patients with hvKp infections than those with cKp (42.1% in hvKp vs. 4.9% in cKp, p ≤ 0.001). Differences between hvKp and cKp groups are shown in Table 7.
Table 7.
Differences between hvKp and cKp groups.
| Characteristic | hvKp (n = 19) No. (%) | cKp (n = 101) | p-Value |
|---|---|---|---|
| Basic demographics: | |||
| Age (mean ± SE) | 31.26 ± 0.47 | 55.63 ± 1.43 | <0.001 |
| Male | 10 (52.6%) | 56 (56.4%) | 0.822 |
| K-serotype: | |||
| K1 | 8 (42.1%) | 3 (2.97%) | <0.001 |
| K2 | 4 (21%) | 2 (1.98%) | 0.004 |
| K5 | 0 (00.00%) | 0 (00.00%) | - |
| K20 | 0 (00.00%) | 0 (00.00%) | - |
| K57 | 1 (5.3%) | 5 (4.95%) | 0.954 |
| Non typable | 6 (31.6%) | 91 (90.1%) | 0.001 |
| Virulence-associated Genes: | |||
| rmpA | 16 (84.2%) | 16 (15.8%) | <0.001 |
| rmpA2 | 14 (73.7%) | 18 (17.8%) | <0.001 |
| magA | 15 (78.9%) | 27 (26.7%) | 0.037 |
| Aerobactin | 19 (100%) | 6 (5.9%) | <0.001 |
| Hypermucoviscosity: | 19 (100%) | 8 (7.9%) | <0.001 |
| Underlying Diseases: | |||
| Diabetes | 15 (78.9%) | 36 (35.6%) | 0.003 |
| Cancer | 2 (10.5%) | 13 (12.8%) | 0.253 |
| Pulmonary diseases | 10 (52.6%) | 44 (43.6%) | 0.064 |
| Chronic renal failure | 0 (00.00%) | 2 (1.9%) | - |
| Invasive Devices: | 8 (42.1%) | 5 (4.9%) | <0.001 |
4. Discussion
The variant hvKp is an increasingly reported pathotype of K. pneumoniae characterized clinically by its capability to cause metastatic and life-threatening infections in immunocompetent and young healthy individuals. In our study, the hypermucoviscous phenotype (based on the string test) was identified in 22.5% of all K. pneumoniae strains and this phenotype was significantly higher in hvKp strains. Another study performed in Egypt reported that the hypermucoviscous phenotype was detected in about 40% of K. pneumoniae isolates [22]. This discrepancy may be due to the difference in sample size.
In this study, hvKp (identified as hypermucoviscous- and aerobactin-positive) accounted for 15.8% of all HA K. pneumoniae infections in ICUs. This is in line with previous studies that showed that the prevalence of hvKp ranged from 7.8% to 25.4 [23,24].
Our results showed that the mean age of hvKp-infected patients was significantly younger than that of cKp-infected patients and invasive infections were significantly higher in patients with hvKp infections. These results are consistent with previous reports that showed that hvKp frequently causes invasive infections in young people without underlying disease [25,26,27,28].
Regarding antimicrobial resistance and ESBL production, our results showed that the resistance rate to common antibiotics in hvKp strains was significantly lower than in cKp strains and that ESBL production was more frequent in the cKp strains than in the hvKp strains. This was in accordance with another study conducted in China that reported the same findings [29]. In another study, the population genomics data suggested that acquisition of antimicrobial resistance plasmids by hvKp was more difficult than in cKp. The authors postulated that this may be due to the hyper-expression of the capsule, which may provide a physical barrier against the acquisition of antimicrobial resistance plasmids [30]. However, another study conducted in Egypt reported that there was no significant difference between hvKp and cKp strains regarding the antimicrobial resistance pattern [31]. The reason for this discrepancy may be due to the difference in sample size.
Regarding biofilm formation and serum resistance assay, our study showed that the hvKp isolates were highly associated with moderate and strong biofilm formation than the cKp isolates. Moreover, the hvKp isolates were highly associated with intermediate sensitivity and resistance to the serum in serum resistance assay than the cKp isolates. This is in agreement with a previous study that reported the same findings [32]. In contrast, another study conducted in Egypt reported that there was no significant difference between hvKp and cKp regarding biofilm formation and serum resistance assay [31]. This discrepancy may be attributed to the difference in sample size.
Regarding the virulence factors, the capsule is considered the major virulence factor in K. pneumoniae; there are several types of K-antigens [33,34,35]. K1 and K2 are the most important serotypes as they frequently result in severe infections [36,37]. In this study, K1 and K2 were significantly higher in hvKp than in cKp strains. The genes responsible for the hypermucoviscous phenotype (rmpA, mpA2 and MagA) are considered another virulence determinants in addition to K1/K2 [14,15,38,39]. Our results showed that rmpA, rmpA2 and magA were significantly associated with hvKp strains. These results are consistent with a previous study, which reported that there was a significant association between these genes and hvKp but not with cKp [29]. Aerobactin is considered a crucial virulence determinant of hvKp. In agreement with another study, our results showed that aerobactin was significantly associated with hvKp [40]. Therefore, these results showed that most of the virulence factors are more strongly associated with hvKp than with cKp.
Aligning with the results of a previous study, our results revealed that diabetes mellitus was a statistically significant risk factor associated with hvKp infections and that there were no significant differences between hvKp and cKp strains regarding other underlying conditions of patients [31].
5. Conclusions
The hvKp strains have emerged as a new threat to ICU patients because of their ability to cause more severe and life-threatening infections than cKp. The string test alone as a laboratory test for screening of hvKp has become insufficient. Recently, hvKp has been defined as hypermucoviscous- and aerobactin-positive. It is important to improve the awareness towards the diagnosis and management of hvKp infections. Antibiotic resistance, biofilm formation and biofilm-related genes were studied to evaluate their relationships with one another and with the genetic genotypes and phenotypes of hvKp isolated from clinical settings. Analysis of our data showed that genes have a role in biofilm formation and antibiotic resistance patterns. These methods may help shed light on the connections between hvKp biofilm formation and antibiotic resistance, as well as the transmission pathways of clinical isolates. Further insight into the link between biofilm production and antibiotic resistance might aid in the fight against drug-resistant bacteria.
Acknowledgments
The authors would like to thanks the University of Jeddah for its technical and financial support.
Abbreviations
Kp: Klebsiella pneumoniae. HAIs: hospital-acquired infections. cKp: classical K. pneumoniae. hvKp: Hypervirulent Klebsiella pneumoniae. PLA: pyogenic liver abscesses. MHC: major histocompatibility complex. hmvKp: hypermucoviscous K. pneumonia. rmpA: regulator of mucoid phenotype. magA: mucoviscosity-associated gene. HA: hospital-acquired. ICU: intensive care unit. ESBL: extended-spectrum-β-lactamase. VCs: viable counts. PCR: polymerase chain reaction. SPSS: Statistical Package for Social Sciences.
Author Contributions
Conceptualization, M.T.A.; M.S.A.; S.S. and O.A.F.; methodology, M.T.A.; M.S.A.; M.K.N.; M.K.T.; M.H.A.; H.S.G.; A.A.; Y.A.; S.M.Z.; S.K.A.J.; S.S. and O.A.F.; software, S.K.A.J. and S.S.; validation, M.T.A.; M.S.A.; S.S. and O.A.F.; formal analysis, M.T.A.; M.S.A.; S.S. and O.A.F.; investigation, M.T.A.; M.S.A.; M.K.N.; M.K.T.; M.H.A.; H.S.G.; A.A.; Y.A.; S.M.Z.; S.K.A.J.; S.S. and O.A.F.; resources, M.T.A.; M.S.A.; S.S. and O.A.F.; data curation, M.T.A.; M.S.A.; S.S. and O.A.F.; writing—original draft preparation, M.T.A.; M.S.A.; M.K.N.; M.K.T.; M.H.A.; H.S.G.; A.A.; Y.A.; S.M.Z.; S.K.A.J.; S.S. and O.A.F.; writing—review and editing, M.T.A.; M.S.A.; M.K.N.; M.K.T.; M.H.A.; H.S.G.; A.A.; Y.A.; S.M.Z.; S.K.A.J.; S.S. and O.A.F.; visualization, M.T.A.; M.S.A.; S.S. and S.K.A.J.; supervision, M.T.A.; M.S.A.; S.S. and S.K.A.J.; project administration, M.T.A.; M.S.A.; S.S. and S.K.A.J.; funding acquisition, M.T.A.; M.S.A.; S.S. and S.K.A.J. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
The reported experiments were performed in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013 (http://ethics.iit.edu/ecodes/node/3931). Approval was obtained from the Research Ethics Committee, Jouf University (Ethical Approval No. 3-04-43) and Research Ethics Committee, Qurayyat Health Affairs, Registered with NCBE, Reg NO: H-13-S-071, Saudi Arabia as a part of (Project No. 111). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. In this study, written consent was obtained from each patient.
Informed Consent Statement
Informed consent was been obtained from every patient.
Data Availability Statement
Available upon request.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This work was funded by the University of Jeddah, Jeddah, Saudi Arabia, under grant No. (UJ-22-DR-115).
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Gupta A. Hospital-acquired infections in the neonatal intensive care unit-Klebsiella pneumoniae. Semin. Perinatol. 2002;26:340–345. doi: 10.1053/sper.2002.36267. [DOI] [PubMed] [Google Scholar]
- 2.Ko W.C., Paterson D.L., Sagnimeni A.J., Hansen D.S., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., Mulazimoglu L., Trenholme G., et al. Community-acquired Klebsiella pneumoniae bacteremia: Global differences in clinical patterns. Emerg. Infect. Dis. 2002;8:160–166. doi: 10.3201/eid0802.010025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Podschun R., Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 1998;11:589–603. doi: 10.1128/CMR.11.4.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Casanova C., Lorente J.A., Carrillo F., Perez-Rodriguez E., Nunez N. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch. Intern. Med. 1989;149:1467. doi: 10.1001/archinte.1989.00390060171048. [DOI] [PubMed] [Google Scholar]
- 5.Shon A.S., Bajwa R.P., Russo T.A. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: A new and dangerous breed. Virulence. 2013;4:107–118. doi: 10.4161/viru.22718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Catalan-Najera J.C., Garza-Ramos U., Barrios-Camacho H. Hypervirulence and hypermucoviscosity: Two different but complementary Klebsiella spp. phenotypes? Virulence. 2017;8:1111–1123. doi: 10.1080/21505594.2017.1317412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhang Y., Zeng J., Liu W., Zhao F., Hu Z., Zhao C., Wang Q., Wang X., Chen H., Li H., et al. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China. J. Infect. 2015;71:553–560. doi: 10.1016/j.jinf.2015.07.010. [DOI] [PubMed] [Google Scholar]
- 8.Lin Y.-C., Lu M.-C., Tang H.-L., Liu H.-C., Chen C.-H., Liu K.-S., Lin C., Chiou C.-S., Chiang M.-K., Chen C.-M., et al. Assessment of hypermucoviscosity as a virulence factor for experimental Klebsiella pneumoniae infections: Comparative virulence analysis with hypermucoviscosity-negative strain. BMC Microbiol. 2011;11:50. doi: 10.1186/1471-2180-11-50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhang Y., Zhao C., Wang Q., Wang X., Chen H., Li H., Zhang F., Li S., Wang R., Wang H. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: Geographic distribution, clinical characteristics, and antimicrobial resistance. Antimicrob. Agents Chemother. 2016;60:6115–6120. doi: 10.1128/AAC.01127-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Russo T.A., Olson R., MacDonald U., Beanan J., Davidson B.A. Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infect. Immun. 2015;83:3325–3333. doi: 10.1128/IAI.00430-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Russo T.A., Olson R., MacDonald U., Metzger D., Maltese L.M., Drake E.J., Gulick A. Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect. Immun. 2014;82:2356–2367. doi: 10.1128/IAI.01667-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gu D., Dong N., Zheng Z., Lin D., Huang M., Wang L., Chan E.W.-C., Shu L., Yu J., Zhang R., et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: A molecular epidemiological study. Lancet Infect. Dis. 2018;18:37–46. doi: 10.1016/S1473-3099(17)30489-9. [DOI] [PubMed] [Google Scholar]
- 13.Struve C., Roe C.C., Stegger M., Stahlhut S.G., Hansen D.S., Engelthaler D.M., Andersen P.S., Driebe E.M., Keim P., Krogfelt K.A. Mapping the evolution of hypervirulent Klebsiella pneumoniae. MBio. 2015;6:e00630-15. doi: 10.1128/mBio.00630-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Siu L.K., Yeh K.-M., Lin J.-C., Fung C.-P., Chang F.-Y. Klebsiella pneumoniae liver abscess: A new invasive syndrome. Lancet Infect. Dis. 2012;12:881–887. doi: 10.1016/S1473-3099(12)70205-0. [DOI] [PubMed] [Google Scholar]
- 15.Fang C.-T., Chuang Y.-P., Shun C.-T., Chang S.-C., Wang J.-T. A novel virulence gene in Klebsiella pneumoniaestrains causing primary liver abscess and septic metastatic complications. J. Exp. Med. 2004;199:697–705. doi: 10.1084/jem.20030857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sanchez C.J., Jr., Mende K., Beckius M.L., Akers K.S., Romano D.R., Wenke J.C., Murray C.K. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect. Dis. 2013;13:47. doi: 10.1186/1471-2334-13-47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sahly H., Aucken H., Benedi V.J., Forestier C., Fussing V., Hansen D.S., Ofek I., Podschun R., Sirot D., Tomás J.M., et al. Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 2004;48:3477–3482. doi: 10.1128/AAC.48.9.3477-3482.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Shankar C., Nabarro L.E., Anandan S., Ravi R., Babu P., Munusamy E., Jeyaseelan V., Rupali P., Verghese V.P., Veeraraghavan B. Extremely High Mortality Rates in Patients with Carbapenem-resistant, Hypermucoviscous Klebsiella pneumoniae Blood Stream Infections. J. Assoc. Physicians India. 2018;66:13–16. [PubMed] [Google Scholar]
- 19.Fang C.-T., Lai S.-Y., Yi W.-C., Hsueh P.-R., Liu K.-L., Chang S.-C. Klebsiella pneumoniae genotype K1: An emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin. Infect. Dis. 2007;45:284–293. doi: 10.1086/519262. [DOI] [PubMed] [Google Scholar]
- 20.Nadasy K.A., Domiati-Saad R., Tribble M.A. Invasive Klebsiella pneumoniae syndrome in North America. Clin. Infect. Dis. 2007;45:e25–e28. doi: 10.1086/519424. [DOI] [PubMed] [Google Scholar]
- 21.Lee C.-H., Liu J.-W., Su L.-H., Chien C.-C., Li C.-C., Yang K.-D. Hypermucoviscosity associated with Klebsiella pneumoniae-mediated invasive syndrome: A prospective cross-sectional study in Taiwan. Int. J. Infect. Dis. 2010;14:e688–e692. doi: 10.1016/j.ijid.2010.01.007. [DOI] [PubMed] [Google Scholar]
- 22.Abd-Elmonsef M.M., Khalil H.S., Selim A., Abd-Elsalam S., Elkhalawany W., Samir S., Abd-Elghafar M.S., Abd-Elmonsef M.M.E. Detection of hypervirulent Klebsiella pneumoniae in Tanta University Hospital, Egypt. Br. Microbiol. Res. J. 2016;17:1–10. doi: 10.9734/BMRJ/2016/29240. [DOI] [Google Scholar]
- 23.Togawa A., Toh H., Onozawa K., Yoshimura M., Tokushige C., Shimono N., Takata T., Tamura K. Influence of the bacterial phenotypes on the clinical manifestations in Klebsiella pneumoniae bacteremia patients: A retrospective cohort study. J. Infect. Chemother. 2015;21:531–537. doi: 10.1016/j.jiac.2015.04.004. [DOI] [PubMed] [Google Scholar]
- 24.Ikeda M., Mizoguchi M., Oshida Y., Tatsuno K., Saito R., Okazaki M., Okugawa S., Moriya K. Clinical and microbiological characteristics and occurrence of Klebsiella pneumoniae infection in Japan. Int. J. Gen. Med. 2018;11:293–299. doi: 10.2147/IJGM.S166940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Liu Y.M., Li B.B., Zhang Y.Y., Zhang W., Shen H., Li H., Cao B. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob. Agents Chemother. 2014;58:5379–5385. doi: 10.1128/AAC.02523-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Abdul-Hamid A., Bailey S.J. Klebsiella pneumoniae liver abscess and endophthalmitis. BMJ Case Rep. 2013;2013:bcr2013008690. doi: 10.1136/bcr-2013-008690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Tang L.-M., Chen S.-T., Hsu W.-C., Chen C.-M. Klebsiella meningitis in Taiwan: An overview. Epidemiol. Infect. 1997;119:135–142. doi: 10.1017/S0950268897007930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Chang W.-N., Huang C.-R., Lu C.-H., Chien C.-C. Adult Klebsiella pneumoniae meningitis in Taiwan: An overview. Acta Neurol. Taiwanica. 2012;21:87–96. [PubMed] [Google Scholar]
- 29.Liu C., Guo J. Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: Antimicrobial resistance patterns, molecular epidemiology and risk factor. Ann. Clin. Microbiol. Antimicrob. 2019;18:4. doi: 10.1186/s12941-018-0302-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lam M.M., Wyres K.L., Duchene S., Wick R.R., Judd L.M., Gan Y.-H., Hoh C.-H., Archuleta S., Molton J.S., Kalimuddin S., et al. Population genomics of hypervirulent Klebsiella pneumoniae clonal group 23 reveals early emergence and rapid global dissemination. Nat. Commun. 2018 doi: 10.1038/s41467-018-05114-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.El-Mahdy R., El-Kannishy G., Salama H. Hypervirulent Klebsiella pneumoniae as a hospital-acquired pathogen in the intensive care unit in Mansoura, Egypt. Germs. 2018;8:140–146. doi: 10.18683/germs.2018.1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Shah R.K., NI Z.H., Sun X.Y., Wang G.Q., Li F. The Determination and Correlation of Various Virulence Genes, ESBL, Serum Bactericidal Effect and Biofilm Formation of Clinical Isolated Classical Klebsiella pneumoniae and Hypervirulent Klebsiella pneumoniae from Respiratory Tract Infected Patients. Pol. J. Microbiol. 2017;66:501–508. doi: 10.5604/01.3001.0010.7042. [DOI] [PubMed] [Google Scholar]
- 33.Cheng N., Yu Y.-C., Tai H.-C., Hsueh P.-R., Chang S.-C., Lai S.-Y., Yi W.-C., Fang C.-T. Recent trend of necrotizing fasciitis in Taiwan: Focus on monomicrobial Klebsiella pneumoniae necrotizing fasciitis. Clin. Infect. Dis. 2012;55:930–939. doi: 10.1093/cid/cis565. [DOI] [PubMed] [Google Scholar]
- 34.Pan Y.-J., Fang H.-C., Yang H.-C., Lin T.-L., Hsieh P.-F., Tsai F.-C., Keynan Y., Wang J.-T. Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J. Clin. Microbiol. 2008;46:2231–2240. doi: 10.1128/JCM.01716-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chuang Y.P., Fang C.T., Lai S.Y., Chang S.C., Wang J.T. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J. Infect. Dis. 2006;193:645–654. doi: 10.1086/499968. [DOI] [PubMed] [Google Scholar]
- 36.Yeh K.-M., Kurup A., Siu L.K., Koh Y.L., Fung C.-P., Lin J.-C., Chen T.-L., Chang F.-Y., Koh T.-H. Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J. Clin. Microbiol. 2007;45:466–471. doi: 10.1128/JCM.01150-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Brisse S., Fevre C., Passet V., Issenhuth-Jeanjean S., Tournebize R., Diancourt L., Grimont P. Virulent clones of Klebsiella pneumoniae: Identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS ONE. 2009;4:e4982. doi: 10.1371/journal.pone.0004982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yu W.-L., Ko W.-C., Cheng K.-C., Lee H.-C., Ke D.-S., Lee C.-C., Fung C.-P., Chuang Y.-C. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin. Infect. Dis. 2006;42:1351–1358. doi: 10.1086/503420. [DOI] [PubMed] [Google Scholar]
- 39.Yeh K.-M., Chang F.-Y., Fung C.-P., Lin J.-C., Siu L.K. magA is not a specific virulence gene for Klebsiella pneumoniae strains causing liver abscess but is part of the capsular polysaccharide gene cluster of K. pneumoniae serotype K1. J. Med Microbiol. 2006;55:803–804. doi: 10.1099/jmm.0.46368-0. [DOI] [PubMed] [Google Scholar]
- 40.Hsieh P.F., Lin T.L., Lee C.Z., Tsai S.F., Wang J.T. Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J. Infect. Dis. 2008;197:1717–1727. doi: 10.1086/588383. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Available upon request.